Prognostic values of baseline, interim and end-of therapy 18F-FDG PET/CT scanning in patients with Follicular lymphoma

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900023183

Enrollment

Unknown

Registered

2019-05-15

Start date

2019-05-21

Completion date

Unknown

Last updated

2019-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Follicular lymphoma

Interventions

Gold Standard:hematological test

Index test:18F-FDG PET/CT

Eligibility

Sex/Gender

All

Age

25 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) aged = 18 years; (2) histologically confirmed; (3) patient undergone baseline PET/CT (B-PET), or /and interim PET/CT (I-PET) after 2-4 cycles of chemotherapy, or/and end-of treatment PET/CT (E-PET) after all planned first-line therapy.

Exclusion criteria

Exclusion criteria: The exclusion criteria were a previously known history of other malignance

Design outcomes

Primary

Measure	Time frame
SUVmax;MTV;TLG;	—

Countries

China

Contacts

Public ContactShengming Deng

The First Affiliated Hospital of Soochow University

dshming@163.com+86 15051510189

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026